查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肺癌筛查市场规模和 2030 年预测 - 按癌症类型、技术、年龄组（50 岁及以上和 50 岁以下）和最终用户（医院、诊断中心等）分類的 COVID-19 影响和全球分析
市场调查报告书
商品编码
1324831

肺癌筛查市场规模和 2030 年预测 - 按癌症类型、技术、年龄组（50 岁及以上和 50 岁以下）和最终用户（医院、诊断中心等）分類的 COVID-19 影响和全球分析

Lung Cancer Screening Market Size and Forecast to 2030 - Global Analysis by Cancer Type, Technology, Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
出版日期: | 出版商: The Insight Partners | 英文 188 Pages | 订单完成后即时交付

价格

肺癌筛查市场规模预计将从2022年的23.265亿美元增长到2030年的43.6395亿美元；预计2022年至2030年復合年增长率为8.2%。

肺癌筛查市场的增长归因于肺癌发病率的上升和政府支持的增加。然而，肺部筛查测试的高成本阻碍了肺癌筛查市场的增长。

肺癌筛查是用于在其他方面健康且患有肺癌高风险的人群中检测肺癌的过程。建议长期吸烟且没有任何肺癌体征或症状的老年人进行肺癌筛查。医生使用肺部 LDCT 扫描来寻找肺癌。如果早期发现肺癌，则更有可能通过治疗治愈。

政府支持力度的加大正在推动肺癌筛查市场的增长

美国预防服务工作组建议，年龄在55 岁至80 岁之间，有每年30 包（相当于每天吸20 支香烟，持续30 年）吸烟史、目前正在吸烟或在过去15 年内已戒烟的人进行年度低烟度检查。 - 肺癌剂量计算机断层扫描（LDCT）筛查。

根据《澳大利亚癌症 2023》报告，肺癌是澳大利亚最常见的癌症，占死亡率的大部分。此外，早期发现肺癌有助于提高生存率。此外，新的筛查计划将有助于在治疗不太可能成功的早期阶段发现肺癌。例如，2021 年 7 月，澳大利亚癌症协会与健康和老年护理部合作，确定澳大利亚肺癌筛查计划的可行性。

政府不断增加的支持、政策和多国政府的批准正在推动肺癌筛查市场的增长。

肺癌筛查市场 - 癌症类型洞察

根据癌症类型，肺癌筛查市场分为非小细胞肺癌和小细胞肺癌。 NSCLC 细分市场在 2022 年占据最大市场份额，预计在预测期内復合年增长率为 10.3%。该细分市场的市场地位归因于全球非小细胞肺癌病例的不断增加。 NSCLC 的发展速度比小细胞肺癌慢。在确诊时，它通常会扩散到患者身体的其他部位。因此，早期诊断和治疗至关重要。根据美国国家癌症研究基金会的数据，每 10 例诊断中就有近 9 例患有非小细胞肺癌。根据同一来源，大细胞未分化癌肺癌约占所有 NSCLC 诊断的 10-15%。

肺癌筛查市场 - 技术洞察

根据技术，肺癌筛查市场分为LDCT、胸部X光检查、液体活检等。 LDCT 在 2022 年占据最大市场份额，预计在预测期内復合年增长率为 8.0%。

肺癌筛查市场 - 年龄组洞察

根据年龄组，肺癌筛查市场分为 50 岁及以上和 50 岁以下。 2022 年，50 岁及以上细分市场占据最大市场份额，但 50 岁以下人群预计将以 8.9% 的复合年增长率增长预测期。

肺癌筛查市场 - 最终用户洞察

根据最终用户，肺癌筛查市场分为医院、诊断中心等。到 2022 年，医院细分市场占据最大市场份额，但其他细分市场预计在预测期内将以 8.7% 的复合年增长率增长。

肺癌筛查市场 - 最新动态：

肺癌筛查市场的公司高度采用併购等无机和有机策略。下面列出了最近的一些主要市场发展：

2021年11月，GE医疗与Optellum合作推进肺癌精准诊断和治疗。两家公司正在共同寻求解决诊断肺癌的最大挑战之一，帮助提供者确定肺结节的恶性程度：可能是良性或癌性的可疑病变。

2022年6月，皇家飞利浦与Biodesix, Inc.合作，将Biodesix的Nodify Lung基于血液的肺结节风险评估测试结果纳入飞利浦Lung Cancer Orchestrator肺癌患者管理系统。蛋白质组学数据的结合- 以及目前用于确定治疗决策的放射学和患者病史数据，可以通过在Biodesix Nodify Lung 应用程序中的上下文启动，帮助癌症护理中心在管理越来越多的肺结节病例方面提高诊断效率。肺癌协调员。

2021年5月，泛生子控股有限公司与西门子医疗携手亮相中国医疗器械博览会。此次合作旨在推动泛生子S5平台和肺癌8基因IVD检测在中国医院的大规模应用，为非小细胞肺癌（NSCLC）患者提供高效、准确的个性化诊疗指导。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场细分
    • 全球肺癌筛查市场 - 按技术分类
    • 全球肺癌筛查市场 - 按癌症类型
    • 全球肺癌筛查市场 - 按年龄段
    • 全球肺癌筛查市场 - 按最终用户分类
    • 全球肺癌筛查市场 - 按地理位置

第 2 章：肺癌筛查市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：肺癌筛查市场 - 市场格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 欧洲PEST分析
    • 亚太地区 PEST 分析
    • 南美洲和中美洲 PEST 分析
    • 中东和非洲 PEST 分析
  • 专家意见

第 5 章：肺癌筛查市场 - 主要市场动态

  • 市场驱动因素
    • 肺癌发病率上升
    • 增加政府支持
  • 市场限制
    • 肺癌筛查测试成本高昂
  • 市场机会
    • 结构化肺癌筛查计划
  • 未来的趋势
    • 移动肺癌筛查车
  • 影响分析

第 6 章：肺癌筛查市场 - 全球分析

  • 全球肺癌筛查市场收入预测与分析
  • 全球肺癌筛查市场（按地理位置）-预测与分析

第 7 章：全球肺癌筛查市场 - 2028 年收入和预测 - 按癌症类型

  • 概述
  • 2022 年和 2030 年按癌症类型分類的肺癌筛查市场收入份额 (%)
  • 非小细胞肺癌 (NSCLC)
  • 小细胞肺癌

第 8 章：肺癌筛查市场分析 - 按技术

  • 概述
  • 低剂量计算机断层扫描 (LDCT)
  • 胸部X光检查
  • 液体活检
  • 其他的

第 9 章：肺癌筛查市场分析 - 按年龄组

  • 概述
  • 及较旧的
  • 50以下

第 10 章：肺癌筛查市场分析 - 按最终用户

  • 概述
  • 医院
  • 诊断中心
  • 其他的

第 11 章：肺癌筛查市场 - 2028 年收入和预测 - 地理分析

  • 北美
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太地区其他地区
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：COVID-19 前后对肺癌筛查市场的影响

  • COVID-19疫情对肺癌筛查市场的影响分析

第 13 章：肺癌筛查市场-行业格局

  • 近期增长策略
    • 概述

第 14 章：公司简介

  • Intelerad Medical Systems
  • Nuance Communications Inc
  • GE HealthCare
  • Medtronic
  • Canon Inc.
  • Koninklijke Philips NV
  • Siemens AG
  • CVS Health
  • bioAffinity Technologies, Inc.
  • LungLife AI, Inc.

第 15 章：附录

  • 关于 Insight Partners
  • 专业术语
Product Code: TIPRE00029996

The lung cancer screening market size is expected to grow from US$ 2,326.5 million in 2022 to US$ 4,363.95 million by 2030; it is estimated to record a CAGR of 8.2% from 2022 to 2030.

The lung cancer screening market growth is attributed to the rising lung cancer Incidence and increasing government support. However, the high cost of lung screening tests is hampering the growth of the lung cancer screening market.

Lung cancer screening is a process used to detect lung cancer in otherwise healthy people with a high risk of lung cancer. Lung cancer screening is recommended for older adults who are long time smokers and who don't have any signs or symptoms of lung cancer. Doctors use a LDCT scan of the lungs to look for lung cancer. If lung cancer is detected early, it's more likely to be cured with treatment.

Rising Government Supportis Boosting The Growth Of The Lung Cancer Screening Market

The United States Preventive Services Task Force recommends people aged 55-80 with a 30-pack-year (equivalent to smoking 20 cigarettes per day for 30 years) smoking history who are presently smoking or have quit within the last 15 years to undergo annual low-dose computed tomography (LDCT) screening for lung cancer.

As per the Cancer Australia 2023 report, lung cancer is the most common form of cancer in Australia, accounting for the majority of the mortality rates. Furthermore, early detection of lung cancer helps improve survival rates. Also, the new screening program will help detect lung cancer during the early stages when treatment is not likely to be successful. For example, in July 2021, Cancer Australia partnered with the Department of Health and Aged Care to determine the feasibility of a lung cancer screening program in Australia.

Such rising government support, policies, and approvals by several governments are boosting the growth of the lung cancer screening market.

Lung Cancer Screening Market - Cancer Type Insights

Based on cancer type, the lung cancer screening market is bifurcated into NSCLC and small cell lung cancer. The NSCLC segment accounted for the largest market share in 2022 and is expected to grow at a CAGR of 10.3% during the forecast period. The market position of this segment is due to the rising cases of NSCLC over the globe. NSCLC develops more slowly than small cell lung cancer. It usually spreads to other parts of the patient's body by the time it is diagnosed. Therefore, early diagnosis and treatment are crucial. According to National Foundation for Cancer Research, NSCLC accounts for nearly 9 out of every 10 diagnoses. As per the same source, large-cell undifferentiated carcinoma lung cancer accounts for approximately 10-15% of all NSCLC diagnoses.

Lung Cancer Screening Market - Technology Insights

Based on technology, the Lung cancer screening market is segmented into LDCT, chest X-ray, liquid biopsy, and others. The LDCT accounted for the largest market share in 2022 and same is expected to grow at a CAGR of 8.0% during the forecast period.

Lung Cancer Screening Market - Age Group Insights

Based on age group, the lung cancer screening market is bifurcated into 50 & older and below 50. The 50 & older segment accounted for the largest market share in 2022, however, the below 50 is expected to grow at a CAGR of 8.9% during the forecast period.

Lung Cancer Screening Market - End User Insights

Based on end user, the lung cancer screening market is segmented into hospitals, diagnostic centers, and others. The hospitals segment accounted for the largest market share in 2022, however, the others is expected to grow at a CAGR of 8.7% during the forecast period.

Lung Cancer Screening Market - Recent Developments:

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the lung cancer screening market. A few recent key market developments are listed below:

In November 2021, GE Healthcare and Optellum collaborated to advance precision diagnosis and treatment of lung cancer. Together, the companies are seeking to address one of the largest challenges in diagnosing lung cancer, helping providers to determine the malignancy of a lung nodule: a suspicious lesion that may be benign or cancerous.

In June 2022, Royal Philips teamed up with Biodesix, Inc. to incorporate the results of Biodesix's Nodify Lung blood-based lung nodule risk assessment testing into Philips Lung Cancer Orchestrator lung cancer patient management system. The incorporation of proteomics data - along with the radiologic and patient history data currently used to determine treatment decisions can help create diagnostic efficiency for cancer care centers in the management of a growing number of lung nodule cases via the contextual launch of Biodesix Nodify Lung application within Lung Cancer Orchestrator.

In May 2021, Genetron Holdings Limited has partnered with Siemens Healthineers at the China Medical Equipment Fair. This partnership aims to promote the large-scale application of Genetron's S5 platform and lung cancer 8-gene IVD assay in Chinese hospitals to provide non-small cell lung cancer (NSCLC) patients with efficient and accurate personalized diagnosis and treatment guidance.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the lung cancer screening market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the lung cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Lung Cancer Screening Market - by Technology
    • 1.3.2 Global Lung Cancer Screening Market - by Cancer Type
    • 1.3.3 Global Lung Cancer Screening Market - by Age Group
    • 1.3.4 Global Lung Cancer Screening Market - by End User
    • 1.3.5 Global Lung Cancer Screening Market - by Geography

2. Lung Cancer Screening Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Lung Cancer Screening Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis
  • 4.3 Expert's Opinion

5. Lung Cancer Screening Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Lung Cancer Incidences
    • 5.1.2 Increasing Government Support
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Lung Cancer Screening Tests
  • 5.3 Market Opportunities
    • 5.3.1 Structured Lung Cancer Screening Program
  • 5.4 Future Trends
    • 5.4.1 Mobile Lung Cancer Screening Truck
  • 5.5 Impact Analysis

6. Lung Cancer Screening Market - Global Analysis

  • 6.1 Global Lung Cancer Screening Market Revenue Forecast and Analysis
  • 6.2 Global Lung Cancer Screening Market, by Geography - Forecast and Analysis

7. Global Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type

  • 7.1 Overview
  • 7.2 Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • 7.3 Non-Small Cell Lung Cancer (NSCLC)
    • 7.3.1 Overview
    • 7.3.2 Non-Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
  • 7.4 Small Cell Lung Cancer
    • 7.4.1 Overview
    • 7.4.2 Small Cell Lung Cancer: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Lung Cancer Screening Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Low-Dose Computed Tomography (LDCT)
    • 8.2.1 Overview
    • 8.2.2 Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Chest X-ray
    • 8.3.1 Overview
    • 8.3.2 Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Liquid Biopsy
    • 8.4.1 Overview
    • 8.4.2 Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)

9. Lung Cancer Screening Market Analysis - by Age Group

  • 9.1 Overview
  • 9.2 & Older
    • 9.2.1 Overview
    • 9.2.2 & Older: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Below 50
    • 9.3.1 Overview
    • 9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

10. Lung Cancer Screening Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospitals
    • 10.2.1 Overview
    • 10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)

11. Lung Cancer Screening Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 11.1 North America: Lung Cancer Screening Market
    • 11.1.1 Overview
    • 11.1.2 North America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.1.3 North America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    • 11.1.4 North America: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
    • 11.1.5 North America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    • 11.1.6 North America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.1 US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.1.1 Overview
        • 11.1.6.1.2 US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.1.3 US: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.6.1.4 US: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.1.5 US: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.6.1.6 US: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.2 Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.2.1 Overview
        • 11.1.6.2.2 Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.2.3 Canada: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.6.2.4 Canada: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.2.5 Canada: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.6.2.6 Canada: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.1.6.3 Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.3.1 Overview
        • 11.1.6.3.2 Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.3.3 Mexico: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.1.6.3.4 Mexico: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.6.3.5 Mexico: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.1.6.3.6 Mexico: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.2 Europe: Lung Cancer Screening Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.2.3 Europe: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    • 11.2.4 Europe: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
    • 11.2.5 Europe: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    • 11.2.6 Europe: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.1 Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.1.1 Overview
        • 11.2.6.1.2 Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.1.3 Germany: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.1.4 Germany: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.1.5 Germany: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.1.6 Germany: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.2 UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.2.1 Overview
        • 11.2.6.2.2 UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.2.3 UK: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.2.4 UK: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.2.5 UK: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.2.6 UK: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.3 France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.3.1 Overview
        • 11.2.6.3.2 France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.3.3 France: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.3.4 France: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.3.5 France: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.3.6 France: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.4 Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.4.1 Overview
        • 11.2.6.4.2 Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.4.3 Italy: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.4.4 Italy: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.4.5 Italy: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.4.6 Italy: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.5 Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.5.1 Overview
        • 11.2.6.5.2 Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.5.3 Spain: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.5.4 Spain: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.5.5 Spain: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.5.6 Spain: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.2.6.6 Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.6.1 Overview
        • 11.2.6.6.2 Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.6.3 Rest of Europe: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.2.6.6.4 Rest of Europe: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.6.6.5 Rest of Europe: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.2.6.6.6 Rest of Europe: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.3 Asia-Pacific: Lung Cancer Screening Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.3.3 Asia Pacific: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    • 11.3.6 Asia Pacific: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.1 China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.1.1 Overview
        • 11.3.6.1.2 China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.1.3 China: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.1.4 China: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.1.5 China: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.1.6 China: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.2 Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.2.1 Overview
        • 11.3.6.2.2 Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.2.3 Japan: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.2.4 Japan: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.2.5 Japan: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.2.6 Japan: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.3 India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.3.1 Overview
        • 11.3.6.3.2 India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.3.3 India: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.3.4 India: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.3.5 India: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.3.6 India: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.4 Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.4.1 Overview
        • 11.3.6.4.2 Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.4.3 Australia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.4.4 Australia: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.4.5 Australia: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.4.6 Australia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.5 South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.5.1 Overview
        • 11.3.6.5.2 South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.5.3 South Korea: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.5.4 South Korea: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.5.5 South Korea: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.5.6 South Korea: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.3.6.6 Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.6.1 Overview
        • 11.3.6.6.2 Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.6.3 Rest of Asia Pacific: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.3.6.6.4 Rest of Asia Pacific: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.6.6.5 Rest of Asia Pacific: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.3.6.6.6 Rest of Asia Pacific: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa: Lung Cancer Screening Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.4.3 Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.4.5.1.1 Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.5.2 South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.2.1 Overview
        • 11.4.5.2.2 South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.2.3 South Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.4.5.2.4 South Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.5.2.5 South Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.4.5.2.6 South Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.5.3 Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.3.1 Overview
        • 11.4.5.3.2 Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.3.3 Saudi Arabia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.4.5.3.4 Saudi Arabia: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.5.3.5 Saudi Arabia Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.4.5.3.6 Saudi Arabia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.5.4 UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.4.1 Overview
        • 11.4.5.4.2 UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.4.3 UAE: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.4.5.4.4 UAE: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.5.4.5 UAE Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.4.5.4.6 UAE: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.4.5.5 Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.5.1 Overview
        • 11.4.5.5.2 Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.5.5.3 Rest of Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.4.5.5.4 Rest of Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
        • 11.4.5.5.5 Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.4.5.5.6 Rest of Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
  • 11.5 South & Central America: Lung Cancer Screening Market
    • 11.5.1 Overview
    • 11.5.2 South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.5.3 South & Central America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: Lung Cancer Screening Market, by Technology - 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
    • 11.5.6 South & Central America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.1 Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.1.1 Overview
        • 11.5.6.1.2 Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.1.3 Brazil: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.5.6.1.4 Brazil: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.1.5 Brazil: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.5.6.1.6 Brazil: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.2 Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.2.1 Overview
        • 11.5.6.2.2 Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.2.3 Argentina: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.5.6.2.4 Argentina: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.2.5 Argentina: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.5.6.2.6 Argentina: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
      • 11.5.6.3 Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.3.1 Overview
        • 11.5.6.3.2 Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.3.3 Rest of South & Central America: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
        • 11.5.6.3.4 Rest of South & Central America: Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.6.3.5 Rest of South & Central America: Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
        • 11.5.6.3.6 Rest of South & Central America: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12. Pre and Post COVID-19 Impact on Lung Cancer Screening Market

  • 12.1 Impact Analysis of COVID-19 Pandemic on Lung Cancer Screening Market

13. Lung Cancer Screening Market-Industry Landscape

  • 13.1 Recent Growth Strategies
    • 13.1.1 Overview

14. Company Profiles

  • 14.1 Intelerad Medical Systems
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Nuance Communications Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 GE HealthCare
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Medtronic
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Canon Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Koninklijke Philips NV
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Siemens AG
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 CVS Health
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 bioAffinity Technologies, Inc.
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 LungLife AI, Inc.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. North America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 2. North America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 6. US Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 10. Canada Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 14. Mexico Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Germany Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 22. Germany Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Germany Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Germany Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. UK Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 26. UK Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. UK Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. UK Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. France Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 30. France Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. France Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. France Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Italy Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 34. Italy Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Italy Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Italy Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Spain Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 38. Spain Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Spain Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Spain Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Rest of Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 42. Rest of Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Rest of Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Rest of Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. China Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 50. China Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. China Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. China Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Japan Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 54. Japan Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Japan Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Japan Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. India Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 58. India Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. India Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. India Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Australia Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 62. Australia Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Australia Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Australia Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. South Korea Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 66. South Korea Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. South Korea Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. South Korea Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Rest of Asia Pacific Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 70. Rest of Asia Pacific Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Rest of Asia Pacific Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Rest of Asia Pacific Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Middle East & Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Middle East & Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Middle East & Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Middle East & Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. South Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. South Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. South Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Saudi Arabia Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Saudi Arabia Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Saudi Arabia Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Saudi Arabia Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. UAE Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. UAE Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. UAE Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. UAE Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Rest of Middle East & Africa Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of Middle East & Africa Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Middle East & Africa Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Brazil Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 98. Brazil Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Brazil Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Brazil Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Argentina Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 102. Argentina Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. Argentina Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Argentina Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Rest of South & Central America Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
  • Table 106. Rest of South & Central America Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of South & Central America Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of South & Central America Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Recent Growth Strategies in the Lung Cancer Screening Market
  • Table 110. Glossary of Terms

List Of Figures

  • Figure 1. Lung Cancer Screening Market Segmentation
  • Figure 2. Lung Cancer Screening Market, by Region
  • Figure 3. Global Lung Cancer Screening Market Overview
  • Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Lung Cancer Screening Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Lung Cancer Screening Market, by Geography (US$ Million)
  • Figure 7. Global Lung Cancer Screening Market - Leading Country Markets (US$ Million)
  • Figure 8. North America: PEST Analysis
  • Figure 9. Europe: PEST Analysis
  • Figure 10. Asia Pacific: PEST Analysis
  • Figure 11. South & Central America: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. Experts' Opinion
  • Figure 14. Lung Cancer Screening Market Impact Analysis of Driver and Restraints
  • Figure 15. Global Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
  • Figure 16. Global Lung Cancer Screening Market, by Geography - Forecast and Analysis (2022 & 2030)
  • Figure 17. Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
  • Figure 18. Non-Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Small Cell Lung Cancer: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
  • Figure 21. Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Chest X-ray: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Liquid Biopsy: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
  • Figure 26. & Older: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
  • Figure 29. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. North America: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 33. North America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. North America: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
  • Figure 35. US: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Canada: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Mexico: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Europe: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 39. Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Europe: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
  • Figure 41. Germany: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. UK: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. France: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. Italy: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. Spain: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Rest of Europe: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 47. Asia Pacific: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 48. Asia Pacific Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 49. Asia Pacific: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
  • Figure 50. China: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. Japan: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. India: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. Australia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. South Korea: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 55. Rest of Asia Pacific: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 56. Middle East & Africa: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 57. Middle East & Africa Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 58. Middle East & Africa: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
  • Figure 59. South Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 60. Saudi Arabia: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 61. UAE: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 62. Rest of Middle East & Africa: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 63. South & Central America: Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 64. South & Central America Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 65. South & Central America: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
  • Figure 66. Brazil: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 67. Argentina: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 68. Rest of South & Central America: Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 69. Pre and Post Impact of COVID-19 Pandemic on Markets